Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Norva24 | NORVA | Nov 22, 2024 | 27.25 | +2.83 |
Nosa Plugs | NOSA | Nov 22, 2024 | 0.60 | +1.68 |
Nosium | NOSIUMB | Nov 22, 2024 | 7.64 | +0.26 |
Note | NOTE | Nov 22, 2024 | 127.30 | +0.87 |
Novotek B | NTEKB | Nov 22, 2024 | 67.00 | +0.60 |
Novus Group | NOVU | Nov 22, 2024 | 3.30 | -9.34 |
Nowonomics | NOWO | Nov 22, 2024 | 3.20 | 0.00 |
NP3 Fastigheter | NP3 | Nov 22, 2024 | 246.50 | +4.89 |
NP3 Fastigheter Pref | NP3PREF | Nov 22, 2024 | 30.10 | +1.01 |
NYAB | NYAB | Nov 22, 2024 | 5.39 | +4.66 |
Nyfosa | NYF | Nov 22, 2024 | 103.00 | +2.49 |
Obducat B | OBDUB | Nov 22, 2024 | 1.07 | +1.42 |
Observit | OBSE | Nov 22, 2024 | 0.46 | +4.91 |
ODI Pharma | ODI | Nov 22, 2024 | 3.20 | -3.03 |
Odinwell | ODIN | Nov 22, 2024 | 2.78 | +0.72 |
OEM International B | OEMB | Nov 22, 2024 | 118.40 | +2.25 |
Ogunsen B | OGUNB | Nov 22, 2024 | 31.30 | +0.64 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | Nov 22, 2024 | 301.49 | +0.77 |
OMX NORDIC 40 | OMXN40 | Nov 22, 2024 | 2 615.49 | +2.04 |
OMX Oslo 20 GI | OMXO20GI | Nov 22, 2024 | 1 336.85 | +0.11 |
OMX Oslo 20 PI | OMXO20PI | Nov 22, 2024 | 737.86 | +0.11 |
OMX Stockholm 30 | OMXS30 | Nov 22, 2024 | 2 514.10 | +0.71 |
OMX Stockholm 30 GI | OMXS30GI | Nov 22, 2024 | 493.56 | +0.71 |
OMX Stockholm 60 Cap PI | OMXS60CAP | Nov 22, 2024 | 309.46 | +0.92 |
OMX Stockholm 60 PI | OMXS60PI | Nov 22, 2024 | 290.80 | +0.91 |
OMX Stockholm Automobiles & Parts PI | SX4010PI | Nov 22, 2024 | 1 197.15 | +2.04 |
OMX Stockholm Banks PI | SX3010PI | Nov 22, 2024 | 1 982.91 | -0.52 |
OMX Stockholm Basic Materials PI | SX55PI | Nov 22, 2024 | 2 469.71 | +1.32 |
OMX Stockholm Basic Resources PI | SX5510PI | Nov 22, 2024 | 2 328.65 | +1.31 |
OMX Stockholm Benchmark Cap GI | OMXSBCAPGI | Nov 22, 2024 | 2 245.38 | +0.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.